European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 693-697, September 2006

Roles for the calcium sensing receptor in primary and metastatic cancer

  • A.T. Manning

      Affiliations

    • These authors contributed equally to this paper.
  • ,
  • N. O'Brien

      Affiliations

    • These authors contributed equally to this paper.
  • ,
  • M.J. Kerin

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel: +353 91 544203; fax: +353 91 750509.

Department of Surgery, Clinical Science Institute, University College Hospital, Galway, Ireland

Accepted 22 March 2006.

Abstract 

Aim

To review the role of the calcium sensing receptor (CASR) in colorectal, breast and parathyroid cancers and related cell lines, and to discuss the effects of CASR in the setting of bone metastases from breast cancer.

Methods

We performed a literature search of the PubMed database of the National Library of Medicine (NLM) to identify articles concerning the CASR's involvement in different cancers. Further relevant papers were obtained from the references of those identified in the original search.

Results

Loss of CASR expression is understood to be associated with abnormal differentiation and progression of colorectal carcinoma. It is expressed in both normal and malignant breast tissues and has been implicated in the vicious cycle of bone metastases through its interactions with the parathyroid hormone related peptide (PTHrP). In parathyroid tissue, CASR expression has been linked to proliferation of both parathyroid adenomas and carcinomas.

Conclusion

Apart from its role in calcium homeostasis, the CASR has many diverse functions in a variety of tissue types throughout the body, and is involved in various signalling pathways relating to cell proliferation and differentiation. CASR has been shown to be involved in the progression and spread of a variety of cancers such as colorectal, breast and parathyroid, and is likely to be the focus of much research to further elucidate its precise role.

Keywords: Calcium sensing receptor (CASR), Breast cancer, Colorectal cancer, Parathyroid cancer, Parathyroid hormone-related peptide (PTHrP), Bone metastases

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Sources of support: none declared.

PII: S0748-7983(06)00162-4

doi:10.1016/j.ejso.2006.03.047

European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 693-697, September 2006